Clinical Trials in Austin

Showing 8241-8260 of 15,205 trials

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

NCT01543152

The purpose of the study is to evaluate the safety, tolerability and effect on HIV viral load, of escalating doses of cyclophosphamide administered 1 day prior to SB-728-T infusion.

HIV

Sangamo Therapeutics26 participantsStarted Dec 2011

Los Angeles, California, United States • San Francisco, California, United States • Norwalk, Connecticut, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor

NCT02544451

Study 110 is a Phase 3, multicenter study in subjects aged 6 years and older with cystic fibrosis (CF) who are homozygous for the F508del-CF transmembrane conductance regulator (CFTR) mutation and who participated in Study 109 (NCT02514473) or Study 011B (NCT01897233). Study 110 is designed to evaluate the safety and efficacy of long term treatment of lumacaftor in combination with ivacaftor.

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated246 participantsStarted Aug 2015

Birmingham, Alabama, United States • Tucson, Arizona, United States • Long Beach, California, United States +57 more locations

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor

Find Trials by Condition in Austin

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Registry of Sustained Immunity to COVID-19 Among ESKD Patients

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough

BAX 855 PK-guided Dosing

Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy

Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU

Uphold LITE Post-Market Surveillance Study

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Treatment Protocol of Replagal for Patients With Fabry Disease

Gammagard Liquid and rHuPH20 in PID

Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID

DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

BAX 855 Pediatric Study

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL